Subclinical Hypothyroidism: A Review on Clinical Consequences and Management Strategies

Subclinical hypothyroidism (SCH) is defined as an elevated serum thyroid-stimulating hormone (TSH) level with normal free thyroid hormone values. The prevalence of subclinical hypothyroidism is 3 to 8 percent in the general population, and up to 15 to 18 percent in women who are older than 60 years....

Full description

Saved in:
Bibliographic Details
Published inJournal of medicine Vol. 18; no. 1; pp. 30 - 36
Main Authors Akter, Nazma, Qureshi, Nazmul Kabir, Ferdous, Hossain Shahid
Format Journal Article
LanguageEnglish
Published Dhaka Bangladesh Society of Medicine 2017
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Subclinical hypothyroidism (SCH) is defined as an elevated serum thyroid-stimulating hormone (TSH) level with normal free thyroid hormone values. The prevalence of subclinical hypothyroidism is 3 to 8 percent in the general population, and up to 15 to 18 percent in women who are older than 60 years. It is more common in women than men, and its prevalence increases with age. Of patients with SCH, 80% have a serum TSH of less than 10 mIU/L. Management strategies including screening and treatment of subclinical hypothyroidism are still controversial. The strongest arguments for levothyroxine therapy are the high risk of progression to overt hypothyroidism. Initiating levothyroxine replacement therapy is recommended for all patients with a TSH greater than 10 mIU/L, even if the free thyroxine concentration is within normal laboratory range. However, treatment of patients with a serum TSH level between 5 and 10 mIU/L remains controversial. There was insufficient evidence for a clinically significant relationship between subclinical hypothyroidism and adverse cardiac events or cardiac dysfunction. Conflicting results have been found on the association between subclinical hypothyroidism and cognitive impairment, depression and the risk of fractures. This narrative review aims to assess current evidence on the clinical aspects, as well as screening and treatment recommendations in adults with subclinical hypothyroidism.J MEDICINE January 2017; 18 (1) : 30-36
AbstractList Subclinical hypothyroidism (SCH) is defined as an elevated serum thyroid-stimulating hormone (TSH) level with normal free thyroid hormone values. The prevalence of subclinical hypothyroidism is 3 to 8 percent in the general population, and up to 15 to 18 percent in women who are older than 60 years. It is more common in women than men, and its prevalence increases with age. Of patients with SCH, 80% have a serum TSH of less than 10 mIU/L. Management strategies including screening and treatment of subclinical hypothyroidism are still controversial. The strongest arguments for levothyroxine therapy are the high risk of progression to overt hypothyroidism. Initiating levothyroxine replacement therapy is recommended for all patients with a TSH greater than 10 mIU/L, even if the free thyroxine concentration is within normal laboratory range. However, treatment of patients with a serum TSH level between 5 and 10 mIU/L remains controversial. There was insufficient evidence for a clinically significant relationship between subclinical hypothyroidism and adverse cardiac events or cardiac dysfunction. Conflicting results have been found on the association between subclinical hypothyroidism and cognitive impairment, depression and the risk of fractures. This narrative review aims to assess current evidence on the clinical aspects, as well as screening and treatment recommendations in adults with subclinical hypothyroidism.
Subclinical hypothyroidism (SCH) is defined as an elevated serum thyroid-stimulating hormone (TSH) level with normal free thyroid hormone values. The prevalence of subclinical hypothyroidism is 3 to 8 percent in the general population, and up to 15 to 18 percent in women who are older than 60 years. It is more common in women than men, and its prevalence increases with age. Of patients with SCH, 80% have a serum TSH of less than 10 mIU/L. Management strategies including screening and treatment of subclinical hypothyroidism are still controversial. The strongest arguments for levothyroxine therapy are the high risk of progression to overt hypothyroidism. Initiating levothyroxine replacement therapy is recommended for all patients with a TSH greater than 10 mIU/L, even if the free thyroxine concentration is within normal laboratory range. However, treatment of patients with a serum TSH level between 5 and 10 mIU/L remains controversial. There was insufficient evidence for a clinically significant relationship between subclinical hypothyroidism and adverse cardiac events or cardiac dysfunction. Conflicting results have been found on the association between subclinical hypothyroidism and cognitive impairment, depression and the risk of fractures. This narrative review aims to assess current evidence on the clinical aspects, as well as screening and treatment recommendations in adults with subclinical hypothyroidism.J MEDICINE January 2017; 18 (1) : 30-36
Author Ferdous, Hossain Shahid
Akter, Nazma
Qureshi, Nazmul Kabir
Author_xml – sequence: 1
  givenname: Nazma
  surname: Akter
  fullname: Akter, Nazma
– sequence: 2
  givenname: Nazmul Kabir
  surname: Qureshi
  fullname: Qureshi, Nazmul Kabir
– sequence: 3
  givenname: Hossain Shahid
  surname: Ferdous
  fullname: Ferdous, Hossain Shahid
BookMark eNo1kE1PAjEURRuDiYCu3TZxPdCv6bTuCFExwZiIxuWk03mDJUyL7YDh3zuKrt7mvHtvzggNfPCA0DUlE86Znm5COzlQ5eiEU1qIMzRkpMiznCsxQEOqdZHpQhcXaJTShhAppZBD9L7aV3brvLNmixfHXeg-jjG42qX2Fs_wCxwcfOHg8fwfmgef4HMP3kLCxtf4yXizhhZ8h1ddNB2sHaRLdN6YbYKrvztGb_d3r_NFtnx-eJzPlpmlSnRZrmvOpDQAREhQjRJVXnPLiBRKEaIUSN5UPQKacWNrZhupCkGgEgXLZc7H6OaUu4uhH5W6chP20feVJVWSM0EY1z01PVE2hpQiNOUuutbEY0lJ-WOv_2rLX3vlrz3-DYTSZVw
CitedBy_id crossref_primary_10_1007_s42000_020_00247_1
ContentType Journal Article
Copyright Copyright Bangladesh Society of Medicine 2017
Copyright_xml – notice: Copyright Bangladesh Society of Medicine 2017
DBID AAYXX
CITATION
3V.
7X7
7XB
88E
8FI
8FJ
8FK
8G5
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
GUQSH
K9.
M0S
M1P
M2O
MBDVC
PADUT
PQEST
PQQKQ
PQUKI
PRINS
Q9U
DOI 10.3329/jom.v18i1.31174
DatabaseName CrossRef
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Research Library (Alumni Edition)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
Research Library Prep
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
Research Library
Research Library (Corporate)
Research Library China
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
DatabaseTitle CrossRef
Research Library Prep
ProQuest Central Student
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
Research Library (Alumni Edition)
ProQuest Central China
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest Research Library
Research Library China
ProQuest Medical Library (Alumni)
ProQuest Central Basic
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest Central (Alumni)
DatabaseTitleList Research Library Prep
CrossRef
Database_xml – sequence: 1
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2075-5384
EndPage 36
ExternalDocumentID 4311645931
10_3329_jom_v18i1_31174
GroupedDBID ---
29L
2WC
3V.
5GY
7X7
88E
8FI
8FJ
8G5
8R4
8R5
AAYXX
ABDBF
ABUWG
ADBBV
AFKRA
AHMBA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AZQEC
BAWUL
BENPR
BPHCQ
BVXVI
CCPQU
CITATION
DIK
DWQXO
EBD
EOJEC
ESX
FYUFA
GNUQQ
GUQSH
HMCUK
KWQ
LBD
M1P
M2O
MK0
OBODZ
OK1
PADUT
PQQKQ
PROAC
PSQYO
Q2X
RNS
TR2
TUS
UKHRP
7XB
8FK
K9.
MBDVC
PQEST
PQUKI
PRINS
Q9U
ID FETCH-LOGICAL-c184t-59d3266aee046e8f84b5d3c2064880088e63fb326e923acd2cf68740eb4725653
IEDL.DBID 7X7
ISSN 1997-9797
IngestDate Thu Oct 10 15:54:40 EDT 2024
Thu Nov 21 22:52:46 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c184t-59d3266aee046e8f84b5d3c2064880088e63fb326e923acd2cf68740eb4725653
PQID 1863240239
PQPubID 136215
PageCount 7
ParticipantIDs proquest_journals_1863240239
crossref_primary_10_3329_jom_v18i1_31174
PublicationCentury 2000
PublicationDate 2017-00-00
PublicationDateYYYYMMDD 2017-01-01
PublicationDate_xml – year: 2017
  text: 2017-00-00
PublicationDecade 2010
PublicationPlace Dhaka
PublicationPlace_xml – name: Dhaka
PublicationTitle Journal of medicine
PublicationYear 2017
Publisher Bangladesh Society of Medicine
Publisher_xml – name: Bangladesh Society of Medicine
SSID ssj0066646
Score 2.0393376
Snippet Subclinical hypothyroidism (SCH) is defined as an elevated serum thyroid-stimulating hormone (TSH) level with normal free thyroid hormone values. The...
SourceID proquest
crossref
SourceType Aggregation Database
StartPage 30
SubjectTerms Disease management
Drug therapy
Hypothyroidism
Title Subclinical Hypothyroidism: A Review on Clinical Consequences and Management Strategies
URI https://www.proquest.com/docview/1863240239
Volume 18
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1NSwMxEA3agngRP7FaSw4evMSSTTbbeJFaWorQImKxtyXZJFChu7VbBf-9k_2wevG8Ob3ZmfdmkplB6FokhiqbUCKBewl3jBJtOSVOc6ed1JIy3408mYrxjD_Ow3lVcMurZ5V1TCwCtckSXyPv0p4fLO5bMe9X78RvjfK3q9UKjV3UpAFQOfzP0fwn4QJlXnYX-YmjMpJROdqHsUB237Ll7SftLSgkrTTif1npb1AumGZ0iA4qiYj7pU2P0I5Nj9HepLoEP0Gv4Ox1QyMef6081utsYRb58g73cVntx1mKB_Whwa8n01ilBm8fveB6PK3NT9FsNHwZjEm1H4EkkJdtSCgNiC-hrIUk1_Zcj-vQsCQAlQFeCeHDCuY0HLGg4lRigsQJv4HPah6B0gnZGWqkWWrPEQ5kwpRzSikTcscjpYTQRlEjQxlYoVvopsYnXpVjMGJIHzyUMUAZF1DGBZQt1K7xiyt_yOOt9S7-_3yJ9gNPnEWRo40am_WHvQLa3-hOYdsOaj4Mp0_P3_MZrsI
link.rule.ids 314,780,784,4024,12056,21388,27923,27924,27925,31719,33744,43310,43805
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1NTwIxEG0UEvVi_Iwoag8evFTSbfejXgwSCCoQYyBy27TbNsGEXWTRxH9vu9sNcvHcnt5kZt5MO28AuAkSiblKMGIm9yKqCUZCUYy0oFpoJhgmdhp5OAr6E_o89aeu4Za7b5VVTCwCtcwS2yNv4cgKi9tRzIfFJ7Jbo-zrqluhsQ3qVjndr4H6Y3f0-lbFYsPNy_kiqznKQhaW4j6EeKz1kc3vvnE0w6ZsxSHdzEubYbnINb0DsO9IImyXVj0EWyo9AjtD9wx-DN6Nu1cjjbD_s7BoL7OZnOXze9iGZb8fZinsVJc6fz5NQ55KuP72AiuBWpWfgEmvO-70kduQgBJTma2Qz6ShXwFXypS5KtIRFb4kiWd4hvFLE0BUQLQwV5ThcTyRXqIDu4NPCRoaruOTU1BLs1SdAeixhHCtOefSp5qGnAeBkBxL5jNPBaIBbit84kUphBGbAsJCGRso4wLKuICyAZoVfrHziDxe2-_8_-NrsNsfDwfx4Gn0cgH2PJtGi5ZHE9RWyy91aUjASlw5S_8C1Fmxfg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Subclinical+Hypothyroidism%3A+A+Review+on+Clinical+Consequences+and+Management+Strategies&rft.jtitle=Journal+of+medicine&rft.au=Akter%2C+Nazma&rft.au=Nazmul+Kabir+Qureshi&rft.au=Hossain%2C+Shahid+Ferdous&rft.date=2017&rft.pub=Bangladesh+Society+of+Medicine&rft.issn=1997-9797&rft.eissn=2075-5384&rft.volume=18&rft.issue=1&rft.spage=30&rft_id=info:doi/10.3329%2Fjom.v18i1.31174&rft.externalDocID=4311645931
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1997-9797&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1997-9797&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1997-9797&client=summon